SEC-sourced researchBeta
COYA
Coya Therapeutics, Inc.
Company comparison ↗
Data passport
- CIK
- 0001835022
- Exchange
- Nasdaq
- Business activity
- — · SIC 2834
- Financial inputs
- 6/6
- Filing date
- Oct 5, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2024 | 3,554,061.0000 | Mar 16, 2026 |
| December 2025 | 7,945,753.0000 | Mar 16, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 7,945,753.0000 | -21,226,107.0000 | -10,739,301.0000 | 49,950,245.0000 | 6,922,015.0000 | Mar 16, 2026 |
| December 2024 | 3,554,061.0000 | -14,880,787.0000 | -10,288,822.0000 | 44,347,016.0000 | 4,769,921.0000 | Mar 16, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenues | $7.95M | December 2025 | Mar 16, 2026 | 10-K |
| Previous period revenueRevenues | $3.55M | December 2024 | Mar 16, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$21.23M | December 2025 | Mar 16, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$10.74M | December 2025 | Mar 16, 2026 | 10-K |
| Total assetsAssets | $49.95M | December 2025 | Mar 16, 2026 | 10-K |
| Total liabilitiesLiabilities | $6.92M | December 2025 | Mar 16, 2026 | 10-K |